Emergency Department Utilization Among Cancer Patients Receiving Immune Checkpoint Inhibitors: Patterns, Clinical Characteristics, and Associated Factors
Background: Immune checkpoint inhibitors (ICIs) have become an integral component of cancer treatment across multiple solid and hematologic malignancies. Although these agents can produce durable clinical responses, they are also associated with immune-related adverse events that may lead to emergency department (ED) v...